GSK Center of Excellence for External Drug Discovery (CEEDD)
GSK Legal Department, Business Development Transactions
GlaxoSmithKline, Inc.
Merck & Co. Inc.
Rob is one of the most experienced lawyers in the nation for crafting and negotiating R&D collaborations, complex licensing arrangements and option-based deals in the life sciences. He has deep expertise across a broad range of deal types for therapeutics, diagnostics, cell-based therapies and gene therapy. His deal experience includes major clinical stage co-development and co-commercialization alliances, joint ventures, option-based drug discovery, development and commercialization deals, as well as early stage research collaborations and evaluation agreements.
Rob’s more than 25 years of experience within the pharma and biotech industry are evident in his deep understanding of the nuances and challenges of these types of deals, and his ability to bring a creative problem-solving approach to both the business and legal issues that arise within R&D transactions. Clients also benefit from Rob’s ability to adeptly handle the most complex IP issues in structuring and negotiating deals as a result of his prior experience as a patent attorney.
GSK Center of Excellence for External Drug Discovery (CEEDD)
Vice President, Head of Business Strategy
GlaxoSmithKline, Inc.
Assistant General Counsel, Business Development Transactions
Merck & Co.
Scientific Liaison Associate- External Scientific Affairs
Research Biochemist
Prior to joining Glaxo Smith Kline, Rob was a patent attorney focusing on the preparation and prosecution of biotechnology and pharmaceutical patent applications and freedom to operate analyses at the Philadelphia office of Akin, Gump, Strauss, Hauer & Feld LLP.
Industry Collaborations
Strategic Transactions